Table 1 Correlation between GAS5 expression and clinicopathological factors
Factors | Cases | Expression of GAS5 | P-value | |
|---|---|---|---|---|
| Â | Â | Low | High | Â |
Overall | 43 | 33 | 10 | Â |
Gender | ||||
 Male | 31 | 24 | 7 | 1 |
 Female | 12 | 9 | 3 | |
Age | ||||
 ≤55 | 7 | 5 | 2 | 0.656 |
 >55 | 36 | 28 | 8 | |
Stage | ||||
 Primary tumor |  |  |  |  |
  NMI (Ta+Tis+TI) | 22 | 13 | 9 | 0.009 |
  MI (T2+T3+T4) | 21 | 20 | 1 | |
 Lymph node metastasis | ||||
  Absent (N0) | 14 | 11 | 3 | 1 |
  Present (N1+N2+N3) | 29 | 22 | 7 | |
 Distant metastasis |  |  |  |  |
  Absent (N0) | 40 | 31 | 9 | 0.558 |
  Present (M1) | 3 | 2 | 1 | |
Grade | Â | Â | Â | Â |
 Low grade | 13 | 9 | 4 | 0.458 |
 High grade | 30 | 24 | 6 | |
